Janney Montgomery Scott
TVRD

Janney Montgomery Scott’s Tvardi Therapeutics TVRD Stock Holding History

Janney Montgomery Scott’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-325
Closed -$149K – 2284
2020
Q3 		$149K Sell
325
-38
-10% -$22.1K ﹤0.01% 1961
2020
Q2 		$223K Sell
363
-4
-1% -$2.21K ﹤0.01% 1780
2020
Q1 		$175K Sell
367
-148
-29% -$80.4K ﹤0.01% 1701
2019
Q4 		$299K Sell
515
-63
-11% -$44.2K ﹤0.01% 1710
2019
Q3 		$380K Sell
578
-13
-2% -$10.8K ﹤0.01% 1553
2019
Q2 		$457K Sell
591
-95
-14% -$66.7K ﹤0.01% 1478
2019
Q1 		$485K Sell
686
-118
-15% -$70.6K ﹤0.01% 1414
2018
Q4 		$376K Sell
804
-47
-6% -$30.3K ﹤0.01% 1448
2018
Q3 		$734K Buy
851
+21
+3% +$15.2K 0.01% 1224
2018
Q2 		$572K Sell
830
-125
-13% -$63.5K 0.01% 1315
2018
Q1 		$426K Sell
955
-636
-40% -$308K ﹤0.01% 1410
2017
Q4 		$701K Buy
1,591
+998
+168% +$455K 0.01% 1128
2017
Q3 		$292K Buy
593
+118
+25% +$59.1K ﹤0.01% 1513
2017
Q2 		$263K Sell
475
-257
-35% -$163K ﹤0.01% 1500
2017
Q1 		$485K Sell
732
-1,190
-62% -$636K 0.01% 1175
2016
Q4 		$643K Buy
1,922
+440
+30% +$141K 0.01% 975
2016
Q3 		$445K Sell
1,482
-1,267
-46% -$275K 0.01% 1016
2016
Q2 		$476K Buy
2,749
+1,384
+101% +$301K 0.01% 542
2016
Q1 		$306K Buy
1,365
+125
+10% +$37.3K 0.01% 957
2015
Q4 		$753K Buy
1,240
+540
+77% +$296K 0.02% 644
2015
Q3 		$360K Buy
700
+246
+54% +$165K 0.01% 975
2015
Q2 		$199K Buy
454
+104
+30% +$40.2K ﹤0.01% 1804
2015
Q1 		$127K Sell
350
-31
-8% -$11.7K ﹤0.01% 2249
2014
Q4 		$137K Buy
+381
New +$123K ﹤0.01% 2134

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Janney Montgomery Scott's TVRD Position: Q4 2020 in Review

Janney Montgomery Scott sold out of Tvardi Therapeutics (TVRD) in Q4 2020, closing a stake of 325 shares — an estimated $149K sold.

Janney Montgomery Scott first reported a position in TVRD in Q4 2014 and held it in 24 quarters. The position peaked at $753K in Q4 2015. 155 funds tracked by Wall St. Rank hold TVRD as of Q4 2020.

  • Janney Montgomery Scott reported no remaining Tvardi Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Janney Montgomery Scott sold 325 Tvardi Therapeutics shares in Q4 2020, an estimated $149K.
  • Janney Montgomery Scott first reported a position in Tvardi Therapeutics in Q4 2014 and held it in 24 quarters.
  • Janney Montgomery Scott's Tvardi Therapeutics position peaked at $753K in Q4 2015.
  • 155 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2020.

Based on Janney Montgomery Scott's 13F filing for Q4 2020, filed 25 Jan 2021.